NCT01770392View on ClinicalTrials.gov

Relative Bioavailability of a Single Dose of Nintedanib Given Alone and in Combination With Multiple Doses of Rifampicin

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Healthy
Interventions
DRUG

Nintedanib

single dose administration

DRUG

Rifampicin

single dose once daily for 7 days

DRUG

Nintedanib

single dose administration

Trial Locations (1)

Unknown

1199.162.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01770392 - Relative Bioavailability of a Single Dose of Nintedanib Given Alone and in Combination With Multiple Doses of Rifampicin | Biotech Hunter | Biotech Hunter